Navigation Links
Appellate Court Decides in Favor of Fenwal
Date:6/2/2010

LAKE ZURICH, Ill., June 2 /PRNewswire/ -- The United States Court of Appeals for the Federal Circuit decided today in favor of Fenwal on a patent lawsuit brought by Haemonetics Corporation against Fenwal and Baxter Healthcare Corporation in 2005, Fenwal announced today.  The decision vacates the January 2009 U.S. District Court for Massachusetts verdict against Fenwal as well as the related damages award and injunction.

In its decision today, the U.S. Court of Appeals agreed with Fenwal and reversed the lower court's definition of "centrifugal unit," a central issue in the case.  The appeals court remanded the case to the district court for further proceedings consistent with the appellate court's decision.

A link to the decision by the United States Court of Appeals for the Federal Circuit can be found at http://www.cafc.uscourts.gov/opinions/09-1557.pdf.

"This decision brings us meaningfully closer to putting this litigation behind us and assuring blood centers of continued supply of Alyx® kits," said Dean Gregory, Fenwal senior vice president of Commercial Operations.  "Our priority from the beginning has been to make sure we support our customers in ensuring a safe and available blood supply as we defend ourselves against unwarranted claims.  I want to thank the many blood centers who stood by us in so many ways as we have worked through the legal process."

About Fenwal

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components. Fenwal is unique in the depth of its experience and commitment to transfusion medicine. The company offers the broadest range of products for the automated and manual collection of blood and blood components.  Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories.  Fenwal developed the first flexible, single-use container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components.  Today, the company's products and advanced collection and separation technologies are used to help treat patients on six continents.  Fenwal, Inc. is based in Lake Zurich, Illinois.  For more information, please visit www.fenwalinc.com.


'/>"/>
SOURCE Fenwal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
2. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
3. Pharma CI Conference Amy Yueh Pays $52,000 to Apaporis LLC to Satisfy Judgment Against Her In Superior Court Of New Jersey Case
4. Montana Supreme Court Decision Endangers Most Vulnerable Citizens
5. U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
6. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
7. CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures
8. Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty
9. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
10. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
11. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Md. , Dec. 2, 2016 The ... indication for Jardiance (empagliflozin) to reduce the risk of ... mellitus and cardiovascular disease. "Cardiovascular disease ... type 2 diabetes mellitus," said Jean-Marc Guettier , ... Endocrinology Products in FDA,s Center for Drug Evaluation and ...
(Date:12/2/2016)... Dec. 2, 2016  LifeVac, the revolutionary device that ... the Emergency Response Training and Support Services (ERTSS) training ... have LifeVac become part of the ERTSS mission to ... CEO of LifeVac. "Having an established network of expert ... will help leverage our efforts to spread LifeVac,s message ...
(Date:12/2/2016)... FRANCISCO , Dec. 2, 2016  PipelineRx, a ... telepharmacy, will be offering demonstrations of its SaaS-based ... Society of Health-System Pharmacists 2016 Midyear Clinical Meeting ... Vegas . With nearly 300 hospital clients ... services and technology designed to dramatically improve pharmacy ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... proudly announces the launch of its 60-day free trial program for all of ... shipping make the offer a truly hassle free experience. , FlexiSpot’s unique desktop ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... ... December 02, 2016 , ... The PAINWeekEnd Regional Conference will ... Spa in Honolulu, offering local frontline clinicians the opportunity to extend their certified ... demand for supplemental training related to pain management has surged dramatically in recent ...
(Date:12/2/2016)... Aliso Viejo, California (PRWEB) , ... December 02, 2016 , ... ... that will allow FCPX editors to create versatile lower third titles with just a ... , Pro3rd Accents Volume 2 includes 30 lower third animations. Choose from various ...
(Date:12/2/2016)... ... 2016 , ... ‘Tis the season for giving! Today, 20 creative teams across ... Partnership and the Drug Enforcement Administration as part of the National Red Ribbon Week ... schools who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. Be ...
Breaking Medicine News(10 mins):